The Amala Cancer Research Center concluded that lectin, a cancer-causing toxin found in Phaseolamin is too small to render such an effect to the human body.
Concluding that there is absolutely no toxicity in Phaseolamin, the Amala Cancer Research Center reveals the following findings:
- There was no mortality or adverse reaction in any of the groups after they were given the doses indicated above.
- There was no significant weight change in any of the animals.
- Food consumption in all the groups remained unchanged compared to controls.
- Liver function tests indicated that acute administration of the ingredient at the doses given did not produce any change in the liver function tests such as GOT, GPT, ALP, Bilirubin, total protein and Albumin/Globulin ratio.
- Acute administration of the ingredient did not produce any change in the renal function as indicated by serum urea, creatinine and electrolyte levels.
- Acute administration of the ingredient did not produce any change in the hematological parameters such as total WBC, differential count and platelets.
- The organ weights of the liver, kidney, spleen were unchanged upon treatment with the ingredient.
- There was no change noticed upon necropsy of the animals and histopathology of liver and kidney of the Phase 2™ treated group were normal and similar to controls.
Hiç yorum yok:
Yorum Gönder